T1	Disease 157 174	Colorectal cancer
T2	Disease 86 99	rectal cancer
T3	Treatment 16 65	neoadjuvant chemoradiotherapy with 5-fluorouracil
T4	NumberOfSamples 846 858	twenty-three
T5	Treatment 464 494	neoadjuvant radio-chemotherapy
T6	Treatment 507 521	5-fluorouracil
T7	Treatment 496 500	NRCT
T8	Treatment 523 527	5-FU
*	Equiv T5 T7
*	Equiv T6 T8
T10	NumberOfSamples 1112 1124	twenty-three
T11	FactorValue 1186 1200	non-responders
T12	FactorValue 1202 1204	NR
T13	FactorValue 1207 1225	partial responders
T15	FactorValue 1235 1251	total responders
T16	FactorValue 1253 1255	TR
T17	FactorValue 1227 1229	PR
T9	Disease 6572 6589	colorectal cancer
T14	Disease 6591 6594	CRC
*	Equiv T9 T14
T18	DiseaseTreatment 6611 6716	radiotherapy (RT) with a concomitant chemotherapy (CT), in a neoadjuvant situation (preoperatively) (NRCT
T19	FactorValue 7169 7180	no response
T20	FactorValue 7182 7184	NR
T22	FactorValue 7233 7249	partial response
T23	FactorValue 7295 7312	complete response
T24	FactorValue 7251 7253	PR
T25	FactorValue 7314 7316	TR
*	Equiv T19 T20
*	Equiv T22 T24
*	Equiv T23 T25
T21	ReductionReagent 7993 8007	dithiothreitol
T26	AlkylationReagent 8025 8038	iodoacetamide
T27	CleavageAgent 8102 8109	trypsin
T28	Disease 11212 11215	CRC
T29	AlkylationReagent 12934 12947	iodoacetamide
T30	ReductionReagent 12875 12889	dithiothreitol
T31	CleavageAgent 13043 13050	tryptic
T32	CleavageAgent 14231 14238	tryptic
T33	SampleTreatment 893 897	FFPE
T34	SampleTreatment 859 891	formalin-fixed paraffin-embedded
*	Equiv T34 T33
T35	SampleTreatment 7378 7382	FFPE
T36	SampleTreatment 7685 7689	FFPE
T37	SampleTreatment 7848 7852	FFPE
T38	SampleTreatment 8483 8515	formalin-fixed paraffin-embedded
T39	SampleTreatment 8478 8482	FFPE
*	Equiv T39 T38
T40	SampleTreatment 11140 11144	FFPE
T41	MS2MassAnalyzer 15895 15903	OrbiTrap
T42	Instrument 15904 15913	QExactive
T43	MS2MassAnalyzer 16162 16170	Orbitrap
T44	CollisionEnergy 16388 16391	35%
T45	FragmentationMethod 16328 16358	collision induced dissociation
T46	NumberOfMissedCleavages 17190 17191	2
T47	Modification 17237 17269	carbamidomethylation on cysteine
A1	Modification T47 fixed
T48	Modification 17363 17383	methionine oxidation
A2	Modification T48 variable
T49	Modification 17388 17417	protein N-terminal acetylatio
A3	Modification T49 variable
T50	PrecursorMassTolerance 17438 17443	7 ppm
T51	FragmentMassTolerance 17467 17473	20 ppm
T52	Separation 15463 15499	Dionex Ultimate 3000 nanoHPLC system
